Post job

Bracket main competitors are Cytel, Vertex Pharmaceuticals, and Alexion Pharmaceuticals.

Competitor Summary. See how Bracket compares to its main competitors:

  • Vertex Pharmaceuticals has the most employees (3,400).
  • Employees at Cytel earn more than most of the competitors, with an average yearly salary of $104,401.
  • The oldest company is Cytel, founded in 1987.
Work at Bracket?
Share your experience

Bracket vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
2001
4.4
Wayne, PA6$200.0M200
1989
4.6
Boston, MA5$11.0B3,400
2008
4.2
Wayne, PA1$16.6M350
1987
4.5
Cambridge, MA2$49.9M1,000
2010
3.7
Willow Grove, PA1$3.0M266
1992
4.6
Boston, MA3$6.1B2,525
2009
4.3
New York, NY1$13.0M600

Rate Bracket's competitiveness in the market.

Zippia waving zebra

Bracket salaries vs competitors

Among Bracket competitors, employees at Cytel earn the most with an average yearly salary of $104,401.

Compare Bracket salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Bracket
$85,052$40.89-
Vertex Pharmaceuticals
$95,952$46.13-
DrugDev
$70,355$33.82-
Cytel
$104,401$50.19-
Azzur Group
$83,336$40.07-
Alexion Pharmaceuticals
$92,699$44.57-

Compare Bracket job title salaries vs competitors

CompanyHighest salaryHourly salary
Bracket
$93,149$44.78
Vertex Pharmaceuticals
$109,035$52.42
Alexion Pharmaceuticals
$103,401$49.71
Cytel
$95,691$46.01
Azzur Group
$80,093$38.51
DrugDev
$79,917$38.42
Kantar Health
$79,811$38.37

Do you work at Bracket?

Does Bracket effectively differentiate itself from competitors?

Bracket jobs

Bracket demographics vs competitors

Compare gender at Bracket vs competitors

Job titleMaleFemale
Kantar Health41%59%
Vertex Pharmaceuticals56%44%
Alexion Pharmaceuticals57%43%
Bracket--
Male
Female

Compare race at Bracket vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
61%13%9%12%4%
9.7
56%14%7%17%6%
9.7
55%18%9%15%3%
9.6

Bracket and similar companies CEOs

CEOBio

Marc’s career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel and GlaxoSmithKline (GSK), has given him extensive industry experience, including finance and accounting; corporate strategy and planning; research and development; sales and marketing; business reorganisation; and business development. Marc is a qualified accountant and joined AstraZeneca in 2013, serving as Executive Vice-President, GPPS from June to October 2013. Prior to that, he served as Global Head of Rare Diseases at GSK and (concurrently) Chairman, GSK Japan. He holds an MBA from HEC, Paris and a Bachelor of Law degree from Paris University.

Reshma Kewalramani M.d
Vertex Pharmaceuticals

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Michael Khavinson
Azzur Group

Lynnette Cooke
Kantar Health

Ibraheem Mahmood
DrugDev

Bracket competitors FAQs

Search for jobs